Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: Feasibility and responsiveness to clinical changes

Lung Cancer

Volumn 61, Issue 3, 2008, Pages 398-404

  Ribi, Karin ^a   Bernhard, Jürg ^a,e   Schuller, Jan C ^a   Weder, Walter ^b   Bodis, Stephan ^c   Jörger, Markus ^d   Betticher, Daniel ^e   Schmid, Ralph A ^e   Stupp, Roger ^f   Ris, Hans Beat ^f   Stahel, Rolf A ^b  

^a SWISS GROUP FOR CLINICAL CANCER RESEARCH SAKK   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c CANTONAL HOSPITAL AARAU   (Switzerland)

^d CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^e UNIVERSITY OF BERN   (Switzerland)

^f UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Individual quality of life; Mesothelioma; Multimodal treatment; RSCL; SEIQoL DW

Indexed keywords

CISPLATIN; GEMCITABINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CHECKLIST; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETERIORATION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; PHASE 2 CLINICAL TRIAL; PLEURA MESOTHELIOMA; PLEUROPNEUMONECTOMY; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SURGICAL PATIENT; TREATMENT OUTCOME;

ADULT; AGED; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM STAGING; PLEURAL NEOPLASMS; QUALITY OF LIFE;

EID: 51049118310     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.01.013     Document Type: Article

References (33)

1. Curran D., Sahmoud T., Therasse P., van Meerbeeck J., Postmus P.E., and Giaccone G. Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. J Clin Oncol 16 (1998) 145-152
2. Hazarika M., White R.M., Booth B.P., Wang Y.C., Ham D.Y., Liang C.Y., et al. Pemetrexed in malignant pleural mesothelioma. Clin Cancer Res 11 (2005) 982-992
3. Cella D.F., Bonomi A.E., Lloyd S.R., Tulsky D.S., Kaplan E., and Bonomi P. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer 12 (1995) 199-220
4. Bergman B., Aaronson N.K., Ahmedzai S., Kaasa S., and Sullivan M. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer 30A (1994) 635-642
5. Hollen P.J., Gralla R.J., Kris M.G., and Potanovich L.M. Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS). Eur J Cancer 29A Suppl. 1 (1993) S51-S58
6. Hickey A., O'Boyle C., McGee H., and Joyce C. The schedule for the evaluation of individual quality of life. In: Joyce C., O'Boyle C.A., and McGee H. (Eds). Individual quality of life: approaches to conceptualization and assessment (1999), Harwood Academic Publisher, Amsterdam 41-49
7. Hickey A.M., Bury G., O'Boyle C.A., Bradley F., O'Kelly F.D., and Shannon W. A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV/AIDS. BMJ 313 (1996) 29-33
8. Bernhard J., Lowy A., Mathys N., Herrmann R., and Hurny C. Health related quality of life: a changing construct?. Qual Life Res 13 (2004) 1187-1197
9. O'Boyle C.A., McGee H., Hickey A., O'Malley K., and Joyce C.R. Individual quality of life in patients undergoing hip replacement. Lancet 339 (1992) 1088-1091
10. Browne J.P., O'Boyle C.A., McGee H.M., McDonald N.J., and Joyce C.R. Development of a direct weighting procedure for quality of life domains. Qual Life Res 6 (1997) 301-309
11. McGee H.M., O'Boyle C.A., Hickey A., O'Malley K., and Joyce C.R. Assessing the quality of life of the individual: the SEIQoL with a healthy and a gastroenterology unit population. Psychol Med 21 (1991) 749-759
12. LeVasseur S.A., Green S., and Talman P. The SEIQoL-DW is a valid method for measuring individual quality of life in stroke survivors attending a secondary prevention clinic. Qual Life Res 14 (2005) 779-788
13. Wettergren L., Bjorkholm M., and Langius-Eklof A. Validation of an extended version of the SEIQoL-DW in a cohort of Hodgkin lymphoma' survivors. Qual Life Res 14 (2005) 2329-2333
14. Montgomery C., Pocock M., Titley K., and Lloyd K. Individual quality of life in patients with leukaemia and lymphoma. Psychooncology 11 (2002) 239-243
15. Waldron D., O'Boyle C.A., Kearney M., Moriarty M., and Carney D. Quality-of-life measurement in advanced cancer: assessing the individual. J Clin Oncol 17 (1999) 3603-3611
16. Campbell S., and Whyte F. The quality of life of cancer patients participating in phase I clinical trials using SEIQoL-DW. J Adv Nurs 30 (1999) 335-343
17. Carlson L.E., Bultz B.D., and Morris D.G. Individualized quality of life, standardized quality of life, and distress in patients undergoing a phase I trial of the novel therapeutic Reolysin (reovirus). Health Qual Life Outcomes 3 (2005) 7
18. Willener R., and Hantikainen V. Individual quality of life following radical prostatectomy in men with prostate cancer. Urol Nurs 25 (2005) 88-90 95-100
19. de Haes J.C., van Knippenberg F.C., and Neijt J.P. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 62 (1990) 1034-1038
20. Fennell D.A., C Steele J.P., Shamash J., Sheaff M.T., Evans M.T., Goonewardene T.I., et al. Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma. Lung Cancer 47 (2005) 277-281
21. Weder W., Stahel R.A., Bernhard J., Bodis S., Vogt P., Ballabeni P., et al. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 18 (2007) 1196-1202
22. Sloan J.A. Assessing the minimally clinically significant difference: scientific considerations, challenges and solutions. Copd 2 (2005) 57-62
23. Nowak A.K., Stockler M.R., and Byrne M.J. Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module. J Clin Oncol 22 (2004) 3172-3180
24. Bottomley A., Gaafar R., Manegold C., Burgers S., Coens C., Legrand C., et al. Short-term treatment-related symptoms and quality of life: results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study. J Clin Oncol 24 (2006) 1435-1442
25. Westerman M., Hak T., The A.M., Groen H., and van der Wal G. Problems eliciting cues in SEIQoL-DW: quality of life areas in small-cell lung cancer patients. Qual Life Res 15 (2006) 441-449
26. Clarke S., Hickey A., O'Boyle C., and Hardiman O. Assessing individual quality of life in amyotrophic lateral sclerosis. Qual Life Res 10 (2001) 149-158
27. Neudert C., Wasner M., and Borasio G.D. Individual quality of life is not correlated with health-related quality of life or physical function in patients with amyotrophic lateral sclerosis. J Palliat Med 7 (2004) 551-557
28. Lee M.A., Walker R.W., Hildreth A.J., and Prentice W.M. Individualized assessment of quality of life in idiopathic Parkinson's disease. Mov Disord 21 (2006) 1929-1934
29. Frick E., Borasio G.D., Zehentner H., Fischer N., and Bumeder I. Individual quality of life of patients undergoing autologous peripheral blood stem cell transplantation. Psychooncology 13 (2004) 116-124
30. Lo Coco G., Lo Coco D., Cicero V., Oliveri A., Lo Verso G., Piccoli F., et al. Individual and health-related quality of life assessment in amyotrophic lateral sclerosis patients and their caregivers. J Neurol Sci 238 (2005) 11-17
31. Bromberg M.B., and Forshew D.A. Comparison of instruments addressing quality of life in patients with ALS and their caregivers. Neurology 58 (2002) 320-322
32. Lintern T.C., Beaumont J.G., Kenealy P.M., and Murrell R.C. Quality of Life (QoL) in severely disabled multiple sclerosis patients: comparison of three QoL measures using multidimensional scaling. Qual Life Res 10 (2001) 371-378
33. Sprangers M.A., and Schwartz C.E. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med 48 (1999) 1507-1515